Consciousness by Woods, James H.
NINETY-SEVENTH ANNUAL CONVENTION OF THE APA DIVISION 28 PROGRAM 1081 
CONSCIOUSNESS. J. H. Woods. University of Michigan, Ann 
Arbor, MI. 
Phencyclidine and ketamine induce in humans a profound 
change in central nervous system function that resembles anesthe- 
sia, i.e., loss of sensitivity to pain and a total amnesia for events 
during intoxication. Ketamine continues to be used in medicine as 
an anesthetic in many places in the world and is used in the U.S. 
extensively in children when burn wounds are treated. In many 
different species of animals both phencyclidine and ketamine can 
be used as anesthetics for many kinds of surgical interventions. 
The mechanism for this profound change in consciousness for 
these drugs is unkown. An increasingly impressive body of 
knowledge is accruing that suggest that some of the behavioral 
effects of excitatory amino anatagonists (NMDA-type) resemble 
some actions of phencyclidine and ketamine. The presentation will 
illustrate that an NMDA antagonist, CGS 19755 (Lehmann et al., 
J. Pharmacol. Exp. Ther. 245:65-76; 1988), can produce an 
anesthetic state in rhesus monkeys that resembles that produced by 
ketamine and phencyclidine. (Research supported by NIDA Grant 
DA-05325.) 
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Chair: Larry Byrd, Yerkes Regional Primate Research Center, 
Emory University, Atlanta, GA 
BEHAVIORAL MEASURES OF OPIOID DEPENDENCE AND 
WITHDRAWAL, Charles P. France. University of Michigan, 
Ann Arbor, MI. 
Discriminative stimulus effects of opioid agonists and antago- 
nists were studied in morphine-treated rhesus monkeys discrimi- 
nating between 0.01 mg/kg of naltrexone and saline while responding 
under a schedule of stimulus-shock termination. Opioid antago- 
nists substituted completely for the naltrexone discriminative 
stimulus and the effective discriminative doses were the same as 
the doses reported to precipitate directly-observable signs of 
withdrawal in morphine-dependent monkeys. Opioid agonists as 
well as nonopioids produced responding on the saline lever. 
Substitution of saline for the daily injection of morphine resulted 
in a time-dependent switch to the naltrexone lever and this effect 
was reversed by opioid agonists. Comparison of studies in which 
antagonists were substituted for naltrexone and studies in which 
antagonists were used to attenuate the withdrawal-reversing ac- 
tions of agonists in morphine-abstinent monkeys showed a strong 
relationship between these methods for estimating antagonist 
affinities. Moreover, pA 2 values determined under these condi- 
tions support the notion that the same receptor subtype mediates a 
wide variety of behavioral effects of morphine in monkeys. 
(Supported by USPHS Grant 05018.) 
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Chair: James E. Smith, Wake Forest University, Bowman Gray 
School of Medicine, Winston-Salem, NC 
WHAT OPERANT "MICROSCOPY"  REVEALS ABOUT THE 
BEHAVIORAL EFFECTS OF ANTIPSYCHOTICS. Stephen C. 
Fowler. University of Mississippi, University, MS. 
Behavioral pharmacological studies using an operant micro- 
scope (i.e., an operant chamber equipped with a force transducer 
operandum and serviced by a laboratory computer) are reviewed. 
This work demonstrates the utility of a dynamic, microanalytic, 
multimeasurement methodology in behavior analysis. More spe- 
cifically, experiments aimed at understanding the associative, 
incentive/motivational, and motor effects of dopamine-receptor 
blocking neuroleptics suggest that the predominant effect of these 
drugs in rats, even at low doses, is a motor impairment remarkably 
similar to Parkinson's disease symptoms in human beings. These 
findings should facilitate the development of preclinical screens 
for identifying and eventually eliminating antipsychotics' extrapy- 
ramidal side effects. 
INVITED ADDRESS 
Chair: Nancy Ator, The Johns Hopkins University School of 
Medicine, Baltimore, MD 
DIFFERENTIAL EFFECTS OF BENZODIAZEPINES ON 
LEARNING AND MEMORY. J. M. Moerschbaecher. LSU 
Medical Center, New Orleans, LA. 
The effects of various benzodiazepines, administered orally, 
were investigated in patas monkeys responding under a multiple 
schedule of i~epeated acquisition and performance of conditional 
discriminations. In both components of the multiple schedule, 
alprazolam, lorazepam, temazepam and triazolam produced dose- 
related decreases in overall response rate. At lower doses, alpra- 
zolam, triazolam and lorazepam also increased errors in acquisition 
while having no effect on errors in performance. Temazepam had 
no effect on errors except at doses which produced substantial 
decreases in response rate. In contrast, diazepam, flurazepam and 
oxazepam had little or no effect on responding. In a second series 
of experiments the effects of alprazolam, temazepam and triazo- 
lam on the retention of conditional discriminations were evaluated. 
Each of these drugs were found to produce both dose- and 
delay-dependent disruptive effects on retention, as measured by 
percent savings in errors to criterion. The data suggest that 
inherent differences exist among the benzodiazepines in terms of 
their effects on complex behavioral processes. Such differences 
may constitute a significant health-related consequence of their use 
in the outpatient or drug abuser. 
SYMPOSIUM 
The Reinforcing Efficacy of Drugs 
Chair: William Woolverton, University of Chicago, Chicago, IL 
INTRODUCTION. 
Drugs of abuse can function as positive reinforcers in humans 
and other animals. Behavior that is maintained by drugs is 
comparable to behavior maintained by standard reinforcers. Fur- 
ther, behavioral variables that influence operant responding have 
similar effects on behavior controlled by drug delivery. However, 
it has been problematic to assess the strength of this behavior in 
response to environmental and pharmacological interventions and 
to compare the ability of different drugs to control responding. 
This difficulty has arisen in part from using rate of responding as 
a measure of reinforcing efficacy. Rate of responding maintained 
by a drug reinforcer is determined not only by its reinforcing 
effects, but by nonspecific rate-modifying effects as well. Thus, 
dose-response functions are typically inverse under ratio and 
